Bone marrow mesenchymal stem cells: Fat on and blast off by FGF21

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 3, 2013, Pages 546-549

  Wan, Yihong ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adipocyte; Bone marrow mesenchymal stem cell; FGF21; Osteoblast; PPAR

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GLUCOSE; SEMAPHORIN 3A; TRIACYLGLYCEROL;

ADIPOCYTE; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL; BONE REGENERATION; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; GAIN OF FUNCTION MUTATION; GLUCOSE BLOOD LEVEL; INSULIN SENSITIVITY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PHENOTYPIC PLASTICITY; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

EID: 84872560326     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.12.014     Document Type: Short Survey

References (30)

1. T. Akune, S. Ohba, S. Kamekura, M. Yamaguchi, U.I. Chung, and N. Kubota PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors Journal of Clinical Investigation 113 2004 846 855
2. M.A. Bredella, P.K. Fazeli, K.K. Miller, M. Misra, M. Torriani, and B.J. Thomas Increased bone marrow fat in anorexia nervosa Journal of Clinical Endocrinology and Metabolism 94 2009 2129 2136
3. C. Canto, and J. Auwerx Cell biology. FGF21 takes a fat bite Science 336 2012 675 676
4. T.F. Day, X. Guo, L. Garrett-Beal, and Y. Yang Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis Developmental Cell 8 2005 739 750
5. P.A. Dutchak, T. Katafuchi, A.L. Bookout, J.H. Choi, R.T. Yu, and D.J. Mangelsdorf Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones Cell 148 2012 556 567
6. P. Dy, W. Wang, P. Bhattaram, Q. Wang, L. Wang, and R.T. Ballock Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes Developmental Cell 22 2012 597 609
7. D.A. Glass 2nd, P. Bialek, J.D. Ahn, M. Starbuck, M.S. Patel, and H. Clevers Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation Developmental Cell 8 2005 751 764
8. M.B. Goldring, and S.R. Goldring Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis Annals of the New York Academy of Sciences 1192 2010 230 237
9. M. Guan, W. Yao, R. Liu, K.S. Lam, J. Nolta, and J. Jia Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass Nature Medicine 18 2012 456 462
10. M. Hayashi, T. Nakashima, M. Taniguchi, T. Kodama, A. Kumanogoh, and H. Takayanagi Osteoprotection by semaphorin 3A Nature 485 2012 69 74
11. T.P. Hill, D. Spater, M.M. Taketo, W. Birchmeier, and C. Hartmann Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes Developmental Cell 8 2005 727 738
12. P.D. Home, S.J. Pocock, H. Beck-Nielsen, P.S. Curtis, R. Gomis, and M. Hanefeld Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Lancet 373 2009 2125 2135
13. K. Johnson, S. Zhu, M.S. Tremblay, J.N. Payette, J. Wang, and L.C. Bouchez A stem cell-based approach to cartilage repair Science 336 2012 717 721
14. J. Justesen, K. Stenderup, E.N. Ebbesen, L. Mosekilde, T. Steiniche, and M. Kassem Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis Biogerontology 2 2001 165 171
15. S.E. Kahn, B. Zinman, J.M. Lachin, S.M. Haffner, W.H. Herman, and R.R. Holman Rosiglitazone-Associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT) Diabetes Care 31 2008 845 851
16. K. Le Blanc, and D. Mougiakakos Multipotent mesenchymal stromal cells and the innate immune system Nature Reviews Immunology 12 2012 383 396
17. Y. Liu, L. Wang, T. Kikuiri, K. Akiyama, C. Chen, and X. Xu Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-Alpha Nature Medicine 17 2011 1594 1601
18. S. Mendez-Ferrer, T.V. Michurina, F. Ferraro, A.R. Mazloom, B.D. Macarthur, and S.A. Lira Mesenchymal and haematopoietic stem cells form a unique bone marrow niche Nature 466 2010 829 834
19. T. Negishi-Koga, M. Shinohara, N. Komatsu, H. Bito, T. Kodama, and R.H. Friedel Suppression of bone formation by osteoclastic expression of semaphorin 4D Nature Medicine 17 2011 1473 1480
20. M.J. Potthoff, S.A. Kliewer, and D.J. Mangelsdorf Endocrine fibroblast growth factors 15/19 and 21: from feast to famine Genes and Development 26 2012 312 324
21. W. Shen, J. Chen, M. Punyanitya, S. Shapses, S. Heshka, and S.B. Heymsfield MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women Osteoporosis International 18 2007 641 647
22. C. Shi, T. Jia, S. Mendez-Ferrer, T.M. Hohl, N.V. Serbina, and L. Lipuma Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands Immunity 34 2011 590 601
23. A. Stolzing, E. Jones, D. McGonagle, and A. Scutt Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies Mechanisms of Ageing and Development 129 2008 163 173
24. E.S. Strotmeyer, and J.A. Cauley Diabetes mellitus, bone mineral density, and fracture risk Current Opinion Endocrinology Diabetes and Obesity 14 2007 429 435
25. Y. Wan PPARgamma in bone homeostasis Trends in Endocrinology and Metabolism 21 2010 722 728
26. Y. Wan, L.W. Chong, and R.M. Evans PPAR-gamma regulates osteoclastogenesis in mice Nature Medicine 13 2007 1496 1503
27. W. Wei, P.A. Dutchak, X. Wang, X. Ding, A.L. Bookout, and R. Goetz Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-Activated receptor gamma Proceedings of the National Academy of Sciences of the United States of America 109 2012 3143 3148
28. W. Wei, X. Wang, M. Yang, L.C. Smith, P.C. Dechow, and Y. Wan PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss Cell Metabolism 11 2010 503 516
29. W. Wei, D. Zeve, J.M. Suh, X. Wang, Y. Du, and J.E. Zerwekh Biphasic and dosage-dependent regulation of osteoclastogenesis by beta-catenin Molecular and Cellular Biology 31 2011 4706 4719
30. B. Zinman, S.M. Haffner, W.H. Herman, R.R. Holman, J.M. Lachin, and B.G. Kravitz Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes Journal of Clinical Endocrinology and Metabolism 95 2010 134 142